BALESTRIERI, PAOLA
 Distribuzione geografica
Continente #
AS - Asia 1.105
NA - Nord America 248
EU - Europa 144
SA - Sud America 85
AF - Africa 9
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.595
Nazione #
SG - Singapore 800
US - Stati Uniti d'America 218
CN - Cina 130
HK - Hong Kong 92
BR - Brasile 62
VN - Vietnam 46
IT - Italia 40
GB - Regno Unito 32
DE - Germania 23
CA - Canada 13
MX - Messico 12
IN - India 10
NL - Olanda 9
EC - Ecuador 8
PL - Polonia 7
AR - Argentina 6
ID - Indonesia 6
JP - Giappone 6
ZA - Sudafrica 5
ES - Italia 4
FR - Francia 4
RU - Federazione Russa 4
UA - Ucraina 4
AU - Australia 3
BD - Bangladesh 3
CZ - Repubblica Ceca 3
SE - Svezia 3
AM - Armenia 2
AT - Austria 2
CO - Colombia 2
EG - Egitto 2
FI - Finlandia 2
IR - Iran 2
LT - Lituania 2
PE - Perù 2
PK - Pakistan 2
PY - Paraguay 2
SI - Slovenia 2
VE - Venezuela 2
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
MQ - Martinica 1
PH - Filippine 1
RO - Romania 1
TH - Thailandia 1
TR - Turchia 1
VC - Saint Vincent e Grenadine 1
Totale 1.595
Città #
Hong Kong 87
Singapore 78
Hefei 68
Ashburn 41
Boardman 33
Beijing 29
Dallas 27
London 27
Ho Chi Minh City 19
Shanghai 19
Rome 18
Hanoi 13
Council Bluffs 11
Los Angeles 10
Munich 7
Warsaw 7
Amsterdam 6
Mexico City 6
San Francisco 6
Seattle 6
Toronto 6
Brooklyn 5
Nuremberg 5
São Paulo 5
Tokyo 5
New York 4
Pune 4
Quito 4
Boydton 3
Cagliari 3
Chicago 3
Hamburg 3
Markham 3
Paris 3
Phoenix 3
Santa Clara 3
Stockholm 3
Apodaca 2
Banī Suwayf 2
Bauru 2
Boston 2
Brno 2
Buenos Aires 2
Canberra 2
Caxias do Sul 2
Charlotte 2
Cotia 2
Guarulhos 2
Guiyang 2
Hưng Yên 2
Itapevi 2
Johannesburg 2
Lima 2
Liverpool 2
Ljubljana 2
Medellín 2
New Delhi 2
Rio de Janeiro 2
West Jordan 2
Yerevan 2
Zapopan 2
Alba Iulia 1
Alvorada 1
Ambato 1
Andradina 1
Angeles City 1
Annapolis 1
Araruama 1
Araçatuba 1
Araçuaí 1
Asunción 1
Baku 1
Bangkok 1
Barquisimeto 1
Belo Horizonte 1
Bengkulu 1
Bertamirans 1
Biên Hòa 1
Blumenau 1
Brasília 1
Bridgetown 1
Buffalo 1
Burbach 1
Bắc Giang 1
Campo Grande 1
Canela 1
Caracas 1
Chelyabinsk 1
Chengdu 1
Chennai 1
Chenzhou 1
Cosmópolis 1
Cuenca 1
Curitiba 1
Da Nang 1
Dhaka 1
Dhanbad 1
Düsseldorf 1
Formosa 1
Fort-de-France 1
Totale 670
Nome #
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients 197
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus 189
Wall Thickness Ratio—A New Magnetic Resonance Parameter—Is Associated With the Outcome of Biological Therapy in Patients With Ileal and Ileocolonic Crohn’s Disease 104
Mathematical Modeling of Vedolizumab Treatment’s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients 94
Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients 92
Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients 78
Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults 53
Nutritional status and bioelectrical phase angle assessment in adult Crohn disease patients receiving anti-TNFα therapy 40
Psychological distress in inflammatory bowel disease 38
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. 36
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease 35
The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough 35
Impedance-High Resolution Manometry Analysis of Patients With Nonerosive Reflux Disease 34
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 30
Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study 27
Intra-bolus pressure and esophagogastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate 26
Nutritional aspects in inflammatory bowel diseases 26
Adalimumab in active ulcerative colitis: A "real-life" observational study 26
Weak peristalsis with large breaks is associated with higher acid exposure and delayed reflux clearance in the supine position in GERD patients 25
Role of Esophageal Motility, Acid Reflux, and of Acid Suppression in Nonobstructive Dysphagia 25
Reflux Patterns and Role of Impedance-pH Variables in Predicting PPI Response in Patients With Suspected GERD-Related Chronic Cough 24
High-resolution Manometry Findings During Solid Swallows Correlate With Delayed Reflux Clearance and Acid Exposure Time in Non-erosive Reflux Disease Patients 23
Role of Overweight and Obesity in Gastrointestinal Disease 22
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study 21
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 21
Role of Mixed Reflux and Hypomotility with Delayed Reflux Clearance in Patients with Non-cardiac Chest Pain 21
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study 20
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS‐CoV‐2 infection: an IG‐IBD study 20
Increased frequency and enhanced perception of reflux in non-erosive reflux disease patients non-responder to proton pump inhibitors 20
Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy 19
Ultrasonography Tight Control and Monitoring in Crohn’s Disease During Different Biological Therapies: A Multicenter Study 19
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study 19
Therapeutic adherence in inflammatory bowel disease: User guide from a multidisciplinary modified Delphi consensus 19
IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame 18
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC) 18
Understanding the relationship between esophageal motor disorders and reflux disease 18
Patients With Extra-Esophageal Symptoms, Compared to NERD Patients With Typical Symptoms and Healthy Volunteers, Arc Characterized by a Higher Number of Reflux Episodes and Higher Proportion of Weakly Acidic and Mixed Reflux 18
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning—the IG-IBD LIVE study 17
REFLUX PATTERN AND ROLE OF IMPEDANCE-PH VARIABLES IN PREDICTING PPI RESPONSE IN PATIENTS WITH SUSPECTED GERD-RELATED CHRONIC COUGH 17
Upadacitinib in Patients With Difficult-to-Treat Crohn’s Disease 16
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 16
Therapeutic drug monitoring is more cost-effective than a clinically based approach in the management of loss of response to infliximab in inflammatory bowel disease: An observational multicentre study 16
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 15
Totale 1.647
Categoria #
all - tutte 12.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.433


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202232 0 0 4 0 0 0 0 0 0 0 0 28
2022/202310 0 0 0 0 1 0 0 0 1 0 8 0
2023/202494 4 11 3 5 6 37 3 6 0 7 9 3
2024/20251.031 22 8 37 3 11 23 23 3 72 71 301 457
2025/2026480 159 116 173 32 0 0 0 0 0 0 0 0
Totale 1.647